HK Stock Market Move | Green Leaf Biotech (02186) fell by over 5% in intraday trading, with an affiliated issuance of exchangeable preferred shares that can be converted into 100 million shares of BOAN BIOTECH (06955).
Green Leaf Biotech subsidiary issued exchangeable preferred shares. As of the time of publication, Green Leaf Biotech (02186) fell by 3.58% to 2.96 Hong Kong dollars; Boan Biotech (06955) fell by 2.92% to 10.63 Hong Kong dollars.
Green Leaf Biotech subsidiary issued exchangeable preferred shares. As of press time, Green Leaf Biotech (02186) fell 3.58% to HK$2.96; BOAN BIOTECH (06955) fell 2.92% to HK$10.63.
In terms of news, LUYE PHARMA announced that its wholly-owned subsidiary Luye Geneora issued 4.75% exchangeable preferred shares to independent third party Bluebell Asset, involving approximately US$150 million, which can be exchanged for up to approximately 100 million shares of BOAN BIOTECH according to the terms of the subscription agreement. The proceeds will be used for general operating purposes of the group. If all are exchanged, BOAN BIOTECH will no longer be a subsidiary of the company.
Related Articles

Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.
Guosen: The final mindset of asset trend convergence.

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


